Sarepta Therapeutics, Inc. Underwriting Agreements
7 Contracts & Agreements
- Underwriting Agreement, October 13, 2021 among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC and Credit Suisse... (Filed With SEC on October 15, 2021)
- Underwriting Agreement, March 5, 2019 among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC, as representatives of the underwriters named... (Filed With SEC on March 7, 2019)
- Underwriting Agreement, dated November 8, 2018, among Sarepta Therapeutics, Inc. and Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC, as... (Filed With SEC on November 9, 2018)
- 2,650,000Shares Sarepta Therapeutics, Inc. Common Stock ($0.0001 par value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on April 24, 2014)
- 4,950,495 Shares of Common Stock par value $0.0001 742,574 Over-Allotment Shares SAREPTA THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on December 18, 2012)
- 20,000,000 Shares of Common Stock par value $0.0001 3,000,000 Over-Allotment Shares AVI BIOPHARMA, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 1, 2011)
- AVI BioPharma, Inc. UNDERWRITING AGREEMENT (Filed With SEC on August 24, 2009)
